MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Jan 16, 2024 | Sale | $59.02 | 1,597 | 94,255 | 117,659 | Jan 18, 2024, 04:45 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Jan 08, 2024 | Sale | $58.92 | 2,090 | 123,143 | 118,625 | Jan 09, 2024, 05:54 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Dec 29, 2023 | Option Exercise | $58.75 | 17,021 | 999,984 | 120,715 | Jan 03, 2024, 06:13 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Dec 13, 2023 | Sale | $56.67 | 2,220 | 125,807 | 103,694 | Dec 14, 2023, 05:05 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Aug 09, 2023 | Option Exercise | $37.00 | 22,297 | 824,989 | 105,914 | Aug 10, 2023, 04:23 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Jan 17, 2023 | Sale | $42.38 | 1,566 | 66,366 | 47,842 | Jan 19, 2023, 09:45 AM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Jan 09, 2023 | Sale | $45.37 | 2,088 | 94,733 | 48,789 | Jan 10, 2023, 05:00 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Dec 21, 2022 | Sale | $40.41 | 3,248 | 131,266 | 50,877 | Dec 21, 2022, 09:20 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Jan 18, 2022 | Sale | $120.48 | 627 | 75,543 | 34,976 | Jan 18, 2022, 08:32 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Jan 07, 2022 | Sale | $135.94 | 1,964 | 266,984 | 24,848 | Jan 07, 2022, 08:27 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Mar 19, 2021 | Sale | $145.38 | 4,738 | 688,826 | 29,181 | Mar 22, 2021, 04:42 PM |
MRTX | | Mirati Therapeutics, Inc. | Hickey Benjamin | EVP, Chief Commercial Officer | Jan 07, 2021 | Sale | $216.33 | 2,078 | 449,525 | 21,858 | Jan 08, 2021, 07:46 PM |
HALO | | HALOZYME THERAPEUTICS, INC. | Hickey Benjamin | SVP, Chief Commerical Officer | Oct 01, 2019 | Option Exercise | $15.46 | 6,990 | 108,065 | 13,226 | Oct 01, 2019, 07:10 PM |